Brief: Starpharma Says Got Regulatory Approval For Viraleze™, In Malaysia
05/06/2023 02:36
June 5 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* ACHIEVED REGULATORY APPROVAL FOR ITS ANTIVIRAL NASAL SPRAY
PRODUCT, VIRALEZE™, IN MALAYSIA
Source text for Eikon: ID:nASXrNskp
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising